Diagnostics & Research
The Diagnostics & Research industry has a total of 52 stocks, with a combined market cap of $665.32 billion, total revenue of $163.73 billion and a weighted average PE ratio of 43.89.
Market Cap
665.32B
Revenue
163.73B
Profits
15.16B
PE Ratio
43.89
Profit Margin
9.26%
Dividend Yield
0.21%
52 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 181.53B | 1.32% | 1,799,787 | 43.21B |
| 2 | DHR | Danaher Corporation | 136.39B | 1.02% | 4,817,664 | 24.01B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 51.66B | 0.26% | 402,579 | 4.04B |
| 4 | A | Agilent Technologies, Inc. | 36.06B | 1.24% | 1,715,222 | 6.79B |
| 5 | IQV | IQVIA Holdings Inc. | 31.76B | 0.45% | 1,005,499 | 15.70B |
| 6 | MTD | Mettler-Toledo International Inc. | 26.29B | 1.27% | 124,222 | 3.87B |
| 7 | NTRA | Natera, Inc. | 24.02B | 1.66% | 783,472 | 1.96B |
| 8 | LH | Labcorp Holdings Inc. | 22.78B | -0.48% | 410,901 | 13.48B |
| 9 | DGX | Quest Diagnostics Incorporated | 20.15B | -0.25% | 549,519 | 10.52B |
| 10 | WAT | Waters Corporation | 18.04B | 1.35% | 515,113 | 3.05B |
| 11 | ILMN | Illumina, Inc. | 15.60B | 0.55% | 1,473,201 | 4.28B |
| 12 | MEDP | Medpace Holdings, Inc. | 13.79B | -1.14% | 200,495 | 2.23B |
| 13 | ICLR | ICON Public Limited Company | 13.47B | 1.60% | 1,333,937 | 8.09B |
| 14 | EXAS | Exact Sciences Corporation | 10.02B | -0.92% | 2,082,928 | 2.94B |
| 15 | RVTY | Revvity, Inc. | 9.90B | 1.52% | 1,196,055 | 2.80B |
| 16 | QGEN | Qiagen N.V. | 9.89B | 0.46% | 918,209 | 2.04B |
| 17 | CRL | Charles River Laboratories International, Inc. | 7.46B | -0.42% | 851,141 | 4.03B |
| 18 | GH | Guardant Health, Inc. | 6.91B | 1.11% | 2,159,266 | 828.85M |
| 19 | RDNT | RadNet, Inc. | 5.72B | -0.83% | 1,200,666 | 1.91B |
| 20 | SHC | Sotera Health Company | 4.63B | 0.43% | 1,641,046 | 1.12B |
| 21 | WGS | GeneDx Holdings Corp. | 3.49B | -0.55% | 720,425 | 362.32M |
| 22 | HTFL | HeartFlow, Inc. | 2.61B | -5.08% | 259,391 | 136.17M |
| 23 | VCYT | Veracyte, Inc. | 2.54B | 1.29% | 523,440 | 479.13M |
| 24 | TWST | Twist Bioscience Corporation | 1.63B | 5.29% | 2,312,914 | 362.27M |
| 25 | GRAL | GRAIL, Inc. | 1.40B | -1.39% | 473,024 | 134.29M |
| 26 | NEOG | Neogen Corporation | 1.14B | -3.66% | 7,114,620 | 894.66M |
| 27 | OPK | OPKO Health, Inc. | 1.10B | 0.72% | 1,889,111 | 664.03M |
| 28 | NEO | NeoGenomics, Inc. | 1.03B | -1.11% | 1,458,453 | 689.19M |
| 29 | CDNA | CareDx, Inc | 754.76M | 1.14% | 1,012,505 | 340.83M |
| 30 | MYGN | Myriad Genetics, Inc. | 697.37M | 2.60% | 1,188,438 | 832.90M |
| 31 | FLGT | Fulgent Genetics, Inc. | 671.56M | -0.18% | 237,237 | 303.22M |
| 32 | CSTL | Castle Biosciences, Inc. | 630.93M | 0.60% | 432,628 | 346.27M |
| 33 | PSNL | Personalis, Inc. | 520.53M | -1.01% | 711,393 | 80.32M |
| 34 | XGN | Exagen Inc. | 200.45M | -2.15% | 180,498 | 58.86M |
| 35 | MDXH | MDxHealth SA | 188.09M | 3.83% | 82,509 | 98.95M |
| 36 | PRE | Prenetics Global Limited | 123.69M | -2.97% | 18,668 | 57.05M |
| 37 | FONR | FONAR Corporation | 101.35M | -0.26% | 19,063 | 104.35M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 98.45M | 11.33% | 117,676 | 4.26M |
| 39 | BNR | Burning Rock Biotech Limited | 91.41M | -2.53% | 46,194 | 74.86M |
| 40 | BDSX | Biodesix, Inc. | 51.17M | -13.68% | 261,500 | 76.56M |
| 41 | NOTV | Inotiv, Inc. | 46.38M | -1.46% | 799,150 | 505.30M |
| 42 | STRR | Star Equity Holdings, Inc. | 35.70M | 3.98% | 31,275 | 137.86M |
| 43 | PRPO | Precipio, Inc. | 29.82M | -1.64% | 11,905 | 21.24M |
| 44 | PRPH | ProPhase Labs, Inc. | 18.04M | 1.02% | 639,002 | 5.59M |
| 45 | CHEK | Check-Cap Ltd. | 14.74M | 18.87% | 17,588,169 | - |
| 46 | ADVB | Advanced Biomed Inc. | 12.16M | 8.06% | 396,080 | - |
| 47 | ISPC | iSpecimen Inc. | 9.36M | -1.17% | 3,786,229 | 5.91M |
| 48 | BIAF | bioAffinity Technologies, Inc. | 7.36M | -25.51% | 13,864,296 | 7.68M |
| 49 | XWEL | XWELL, Inc. | 6.33M | 1.85% | 15,362 | 30.60M |
| 50 | MYNZ | Mainz Biomed N.V. | 5.57M | 2.86% | 70,551 | 893.99K |
| 51 | APDN | Applied DNA Sciences, Inc. | 3.72M | 3.60% | 73,795 | 3.74M |
| 52 | NDRA | ENDRA Life Sciences Inc. | 3.60M | -1.85% | 8,693 | - |